Moleculin Biotech Inc

NASDAQ:MBRX   3:59:48 PM EDT
1.49
+0.05 (+3.47%)
Earnings Announcements

Moleculin Reports First Quarter 2022 Financial Results

Published: 05/12/2022 12:45 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update.company Has Sufficient Capital to Fund Operations Into 2024.
Qtrly Net Loss per Common Share Basic and Diluted $0.24.
Multiple Key Clinical and Regulatory Milestones Expected Throughout 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.